StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
NMTC

NeuroOne Medical Technologies Corporation

NMTC Nasdaq Surgical & Medical Instruments & Apparatus EDGAR ↗
$1.70
+0.00 0.00%

Key statistics

from XBRL data in SEC filings
Market cap
$14.8M
Revenue (TTM)
$9.19M
Net income (TTM)
-$6.94M
EPS (TTM)
$-0.02
P/E ratio
Dividend yield
Free cash flow
-$2.92M
Cash
$2.80M
Total assets
$7.57M
Gross margin
54.4%
52-week range
$1.61 – $6.96

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Other events Jun 12, 2026 10-Q/A Quarter ended 2026-03-31 Jun 12, 2026 8-K Previously issued financials not reliable; Regulation FD disclosure May 22, 2026 10-Q Quarter ended 2026-03-31 May 12, 2026 8-K Results of operations (earnings release) May 12, 2026 8-K Other events May 4, 2026 8-K Director or officer change Apr 30, 2026 8-K Amended charter or bylaws Apr 14, 2026 8-K Director or officer change; Shareholder vote results Apr 3, 2026 8-K Other events Feb 25, 2026 8-K Results of operations (earnings release) Feb 17, 2026 10-Q Quarter ended 2025-12-31 Feb 17, 2026 10-K/A Fiscal year ended 2025-09-30 Jan 23, 2026 8-K Director or officer change; Regulation FD disclosure Dec 22, 2025 8-K Results of operations (earnings release) Dec 17, 2025 10-K Fiscal year ended 2025-09-30 Dec 17, 2025 8-K Delisting notice or listing-rule failure Nov 5, 2025 8-K Results of operations (earnings release); Other events Oct 6, 2025 8-K Other events Aug 18, 2025 8-K Other events Aug 15, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Results of operations (earnings release) Aug 14, 2025 8-K Results of operations (earnings release); Regulation FD disclosure May 13, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 8-K Delisting notice or listing-rule failure May 9, 2025 8-K Entered a material agreement Apr 7, 2025 8-K/A Director or officer change; Shareholder vote results Feb 20, 2025 8-K Shareholder vote results Feb 14, 2025 10-Q Quarter ended 2024-12-31 Feb 12, 2025 8-K Results of operations (earnings release) Feb 12, 2025 8-K Other events Feb 4, 2025 8-K Regulation FD disclosure Jan 14, 2025 8-K Delisting notice or listing-rule failure Jan 10, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Jan 10, 2025 8-K Results of operations (earnings release); Other events Dec 17, 2024 10-K Fiscal year ended 2024-09-30 Dec 17, 2024 8-K Terminated a material agreement Nov 8, 2024 8-K Entered a material agreement; Other events Oct 31, 2024 8-K Director or officer change Sep 13, 2024 8-K Results of operations (earnings release) Aug 14, 2024